Delivery Order SPE2DR25D2217-SPE2DR26FC7EG
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,062.90 to AmerisourceBergen Drug Corp for the supply of Zepbound 2.5 mg/0.5 mL pen injections on September 22, 2025, with an ultimate completion date of September 23, 2025. This award was made under firm fixed-price terms with no set-aside designation, indicating competitive procurement. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a discrete...
- The Defense Logistics Agency awarded a delivery order valued at $6,021.03 to AmerisourceBergen Drug Corp for the supply of Zepbound 2.5 mg/0.5 mL pen injections on August 25, 2025, with completion targeted for August 26, 2025. This competitively awarded, firm fixed price delivery order carries no set-aside designation and will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. The award represents a single transaction under AmerisourceBergen's larger pharmaceutical supply...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,083.86 to AmerisourceBergen Drug Corp for Zepbound 5 mg/0.5 mL pen injections on September 24, 2025. This contract utilizes firm fixed pricing and was competitively awarded without any set-aside designation. The award was fulfilled by AmerisourceBergen's Corporate Office division, with performance at the company's headquarters in Conshohocken, Pennsylvania. The delivery order is scheduled for completion by September 25,...
- The Defense Logistics Agency awarded a delivery order valued at $5,571.34 to AmerisourceBergen Drug Corp for the supply of Zepbound 10 mg/0.5 mL pens on December 2, 2025. This competitive delivery order, utilizing firm fixed pricing with no set-aside designation, represents a single transaction under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $15,083.35 to AmerisourceBergen Drug Corp on November 7, 2025, for the supply of Zepbound 5 mg/0.5 mL pen injections. This is a firm fixed-price delivery order with an ultimate completion date of November 10, 2025, to be performed at the contractor's facility in Conshohocken, Pennsylvania. No set-aside designation was used for this competitive award. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite...
- The Defense Logistics Agency awarded a $2,275.52 firm fixed price delivery order to AmerisourceBergen Drug Corp on November 25, 2025, for the supply of Zepbound 5 mg/0.5 mL pen injections (0.5 mL). The contract, which is classified as a non-set-aside competitive award, is scheduled for completion by November 26, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $17,097.43 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 ml pen injectors on December 10, 2025, with an ultimate completion date of December 11, 2025. This non-competitive delivery order is issued under a firm fixed price arrangement and represents a continuation of AmerisourceBergen's substantial role as a pharmaceutical supplier to the federal government. The work will be performed at the company's corporate...
- The Defense Logistics Agency awarded a delivery order valued at $3,812.94 to AmerisourceBergen Drug Corp for Zepbound 5 mg/0.5 mL pen injections on August 29, 2025, with a completion date of September 2, 2025. This firm fixed-price, non-set-aside delivery order represents a pharmaceutical supply transaction supporting federal medical procurement needs. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, underscoring the company's role as...
- The Defense Logistics Agency awarded a $4,793.92 firm fixed price delivery order to AmerisourceBergen Drug Corp on December 12, 2025, for the supply of Zepbound 5 mg/0.5 mL pen injections, with a completion date of December 15, 2025. This non-set-aside contract represents a small-value transaction within AmerisourceBergen's extensive pharmaceutical distribution portfolio supporting federal medical procurement. The delivery will be fulfilled from the vendor's Conshohocken, Pennsylvania...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Zepbound 12.5 mg/0.5 ml pen injections valued at $2,953.12. This non-set-aside, firm fixed-price delivery order was awarded on November 24, 2025, with an ultimate completion date of November 25, 2025. The product will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen Drug Corp's corporate headquarters. This delivery order is issued under the company's larger...
- SPE2DR25D2217Indefinite Delivery Contract
- SPE2DR25D2217-SPE2DR26FC7EGDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $5,735.03 to AmerisourceBergen Drug Corp for the supply of Zepbound 2.5 mg/0.5 mL pen injections (0.5 mL units) on December 17, 2025, with an ultimate completion date of December 18, 2025. This is a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 and running through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company maintains an extensive portfolio of pharmaceutical products across multiple therapeutic domains through its DLA contracts, which consistently involve firm fixed pricing and demonstrate the contractor's capability to meet federal procurement requirements through open competition. The Zepbound order represents a routine delivery under the broader global pharmaceutical support vehicle that enables AmerisourceBergen to supply medications and medical commodities to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.7k | 12/16/25 |